Recently in Must read Category

PLAGUE – The Best Science Book You Haven’t Read!

What’s REALLY going On In The Autism/Vaccine World…

By Kent Heckenlively, JD

People make choices – what they will see and what will remain invisible to them. Like the character, Neo, played by Keeanu Reeves in The Matrix, we are often given the choice to take the blue pill or the red pill. The blue pill allows you to remain in your safe little world. Taking the red pill, well, that opens a Pandora’s Box.plaguehecki.jpg

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (2 votes cast)

What did they know and When did they know it? Mercury, Vaccines and Autism

KP Stoller, MD   www.incurable-me.com

Source: Bolenreport

A decade before the US Public Health Service (PHS) and the American Academy of Pediatrics (AAP) made a joint public statement vowing to remove the mercury preservative Thimerosal from vaccines (circa 1999), I was trying to find the science behind the recommendation to give newborns the Hep B vaccine (more about that later).

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (1 votes cast)

Vaccine Aluminum Travels Into The Brain

| | Comments (1)

Vaccine Aluminum Travels Into The Brain

Parents can be reassured that the trace quantities of aluminum in vaccines can’t possibly do harm.
-Dr Paul Offit: Vaccine promoter, vaccine patent licensor, and self-appointed autism pundit, 2015



Most vaccines contain aluminum adjuvant, an ingredient necessary for stimulating a strong immune response and immunity. The aluminum is in the form of Al hydroxide and/or Al phosphate nanoparticles.

Aluminum has been used in vaccines since the 1920s. Despite this long history, aluminum adjuvant was not studied much beyond its role in vaccine efficacy. The safety of injected Al adjuvant was assumed, largely because aluminum is a normal (if unhealthy) component of many foods. Its one of the most common elements of the Earths crust. Its everywhere.

  • Currently 3/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 3/5 (2 votes cast)

Where does your doctor’s allegiance lie? Does your healthcare professional listen to your needs and wants as a parent or are they nothing more than affiliate distributors for pharmaceutical companies? It was reported by independent journalist recently that some doctors offices are now demanding their patients sign an immunization contract. What’s an immunization contract you ask? The contract — created outside of law and denying informed consent — requires prospective patients to agree, by signature, to allow 25 vaccines to be injected into their child over a series of visits. Also uncovered in the same investigation, doctors can receive up to $225 per service achieved in the insurance provider category of “childhood immunization [combo 2]”.8244802.png

  • Currently 3.7/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 3.7/5 (3 votes cast)

[5-12-16] Today, the FDA is requiring labeling changes for antibacterial drugs called fluoroquinolones, including an updated boxed warning, stating that the serious side effects associated with fluoroquinolones generally outweigh the benefits for patients with sinusitis, bronchitis and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolones should be reserved for those who do not have alternative treatment options.

  • Currently 3/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 3/5 (2 votes cast)

Including Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax

[Posted 05/10/2016]

AUDIENCE: Psychiatry, Dermatology, Patient

ISSUE: FDA is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. FDA is adding a new warning to the drug labels for all olanzapine-containing products that describes this severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

A search of the FDA Adverse Event Reporting System (FAERS) database identified 23 cases of DRESS reported with olanzapine worldwide since 1996, when the first olanzapine-containing product was approved. FAERS includes only reports submitted to FDA, so there are likely to be additional cases about which FDA is unaware. One patient taking olanzapine experienced DRESS and died; however, this patient was taking multiple medicines that could also have contributed to death (see the Data Summary section of the Drug Safety Communication for more information).

  • Currently 1/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 1/5 (1 votes cast)

Vaccination? Non merci

| | Comments (2)

Vaccination? Non merci

Distrust in vaccines is a growing problem in Europe, especially in France.

By 4/20/16, 3:00 PM CET Updated 5/3/16, 4:06 PM CET

This is the latest in a POLITICO special report on vaccines: the accomplishments, history, controversy and business challenges.

France’s health minister got more than she bargained for when she promised a nationwide debate on the benefits and risks of vaccination this spring.

snake-printfile1-714x873.jpg

  • Currently 1/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 1/5 (1 votes cast)

Another Study Finds Link Between Pharma Money and Brand-name Prescribing

The findings, by researchers at Harvard Medical School, are in line with a similar analysis done by ProPublica in March.

  • Currently 3/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 3/5 (2 votes cast)

Sanofi CEO: Vaccines business 'continues to deliver' with Q1 sales up 8.2%

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

This study estimates changes in reimbursements for orally administered anticancer drugs paid by commercial health plans from 2000 through 2014.

Prescription drug pricing and changes in prices for existing drugs have been under intense scrutiny recently. For anticancer medications, high drug prices have the potential to affect access and adherence to therapies and increase financial burden for patients. Given the rapidly evolving drug pricing landscape, it is important to evaluate recent pricing for anticancer medications. This study’s objectives were to estimate changes in reimbursements for orally administered anticancer drugs paid by commercial health plans from 2000 through 2014, focusing on reimbursements during the year of product launch and changes in reimbursements over time.

Source: http://oncology.jamanetwork.com/article.aspx?articleid=2517398

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Recent Comments

Other sites of ours